Few studies focus on using NGS for tumor specimens, in detecting mutations other than RB1 and no more than a dozen other genes known to occur in retinoblastoma, or in correlating these findings with clinic-histopathologic features [7,12,17,19,20]. This evidence concerns the gene RB1 and neoplasm.